AYTU · Aytu BioPharma Inc
United States · RS rating 30 · As of 2026-11-03
| Price | 1.93 USD |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 44 / 36 / 40 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 13 / 6 / 4 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -1212.5% |
| Sales growth Q/Q | +9.2% |
| Distance from 52-week high | +33.5% |
| Market cap (USD) | $27.0M |